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Pulmonary Balloon Dilation 
for Valvular and Arterial Stenosis 
Edgar C K Ho MD* 
The use of balloon catheters to dilate obstructed vascular 
lesions represents one of the major advances in cardiology and 
dates back to 1964 when Dotter and Judkins3 reported their ex-
perience in dilating arteriosclerotic obstructive lesions. Since that 
time, the technique of balloon dilation has been used extensively 
for coronary and peripheral vascular lesions but also has been 
applied to such diverse cardiac lesions as pulmonic stenosis, 
mitral stenosis, aortic stenosis, aortic coarctation, superior vena 
caval and pulmonary venous obstructions. 
Balloon dilation has been used for both valvular and arterial 
pulmonary stenosis10• The purpose of this study is to report on our 
initial experience in Hawaii with balloon dilation of valvular 
pulmonic stenosis and also with dilation of peripheral pulmonary 
artery stenosis due to congenital causes and as a residual postop-
erative lesion. 
Introduction 
In the field of pediatric cardiology, the first use of a balloon 
dilation catheter was for valvular pulmonic stenosis4• In 1982, Dr. 
Jean Kan at the Johns Hopkins University School of Medicine 
used a balloon catheter to successfully dilate the pulmonic valve 
in an 8-year-old patient. Since that time, there have been other 
cases reported in the world literature2•5•6•9•14•15•18•19•21 • As experience 
accumulated, it became evident that this technique was effective, 
safe, and had many advantages over surgical valvotomy. Today, 
balloon valvuloplasty is considered to be the treatment of choice 
for valvular pulmonic stenosis8• 
Pulmonic stenosis can be divided into valvular, subvalvular 
and supravalvular stenosis. Supra valvular pulmonic stenosis can 
be divided into those lesions involving the main pulmonary artery, 
or either of the main branches or smaller peripheral pulmonary 
artery branches. 
Valvular pulmonic stenosis is one of the more common 
congenital heart anomalies, occurring in 8% to 10% of patients 
with congenital heart disease1• Supravalvular pulmonary artery 
stenosis is less common than valvular stenosis and occurs in only 
2% to 3% of all patients with congenital heart disease11 • 
Methods 
A standard cardiac catheterization and cineangiocardiography 
is performed to measure the valvular pressure gradient and the 
diameter of the valve annulus. After heparinization, a balloon 
catheter is introduced over a guide wire and the center of the 
balloon is positioned over the valve. The balloon size selected is 
20% to 40% larger than the diameter of the valve annulus. The 
balloon is inflated with dilute contrast material with up to 5 
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atmospheres of pressure for a duration of up to 15 seconds to 
achieve the elimination of the "waist" in the balloon which 
represents the constriction of the balloon by the stenotic valve. 
During inflation, the arterial blood pressure and electrocardio-
gramaremonitored. After valvuloplasty, the pressure gradient and 
cineangiocardiogram are repeated. 
The same technique is used for peripheral pulmonary artery 
stenosis except that the balloon sizes are up to 4 times the diameter 
of the obstructed artery segment and inflation pressures are higher. 
Results 
The first case was a 5-year-old girl who was born with 
Tetralogy of Fallot. She had a large ventricular septal defect and 
severe valvular pulmonic stenosis requiring a Blalock-Taussig 
shunt in early infancy to provide adequate pulmonary blood flow. 
At age 3 years, she underwent total correction of her Tetralogy of 
Fallot. The pulmonary valve annulus was very constricting and a 
trans annular patch had to be used to enlarge the pulmonary artery. 
Several years after her surgery, she developed a significant 
residual pulmonary obstruction at the site of the transannular 
patch. At cardiac catheterization, the right ventricular pressure 
was 139 mm Hg and the gradient across the obstruction was 110 
mmHg. 
A 12 mm balloon was selected for the dilation after which the 
right ventricular pressure was reduced to 86 mm Hg and the 
gradient was reduced to 58 mm Hg. Followup Doppler 
echocardiographyrevealeda persistent 54 mmHg systolic gradient. 
A repeat angioplasty 9 months later using a larger 20 mm 
balloon failed to reduce the gradient further, and she was referred 
for surgery. At surgery, the patch was extended to the bifurcation 
of the branch pulmonary arteries. Postoperative Doppler exami-
nation revealed a reduction of the gradient to 36 mm Hg. 
The second case was a 16-year-old girl who was born in the 
Philippines with a large atrial septal defect and severe valvular 
pulmonic stenosis. After immigrating to Hawaii at age 12 years, 
she was found to be severely symptomatic. 
The atrial septal defect was closed at 13 years of age, and at 
the same time, a valvotomy was performed. 
She was reevaluated by Doppler echocardiography 2 years 
after surgery and was found to have a significant residual pulmonic 
gradient. At cardiac catheterization, the right ventricular pressure 
was 110 mm Hg and the valve gradient was 96 mm Hg. The 
subvalvular infundibular area was also hypertrophied. An 18 mm 
balloon was used for the dilation after which the right ventricular 
pressure decreased to 50 mm Hg and the gradient to 38 mm Hg. 
One year later, Doppler echocardiography demonstrated an 
increase of the gradient to 60 mm Hg. A repeat cardiac 
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PULMONARY BALLOON DILATION: (Continued from page 30) 
catheterization confirmed a gradient of 58 mm Hg. Dilation was 
performed with a 23 mm balloon, reducing the gradient Hg. Three 
months later, the gradient by Dopplerechocardiography remained 
at 14mmHg. 
The third case was a 9-year-old boy also born with Tetralogy 
of Fallot with an absent pulmonary valve and hypoplasia of the 
pulmonic annulus. At 3 years of age, he had a total correction and 
a transannu1ar patch was used to relieve the pulmonic stenosis. 
Three years after surgery, cardiac catheterization revealed 
severe residual pulmonic stenosis, and he then had an aortic 
homograft inserted into the right ventricle with the distal end 
connected to the main pulmonary artery, bypassing the obstructed 
annulus. 
At 9 years of age, cardiac catheterization identified an ob-
struction at the junction of the homograft with the main pulmonary 
artery. The right ventricular pressure was 89 mm Hg and the 
gradient across the stenosis was 47 mm Hg. After dilation with a 
20 mm balloon, the right ventricular pressure decreased to 42 mm 
Hg and the gradient was reduced to 4 mm Hg. 
One year later the right ventricular pressure had again in-
creased to 82 mm Hg and the gradient to 56 mm Hg by 
catheterization. The patient is awaiting surgical angioplasty; it 
appears the stenosis was relieved only temporarily by the dilation. 
The fourth case was a 14-month-o1d boy with a combined 
valvular and supravalvular stenosis. At cardiac catheterization, 
the right ventricular pressure was 72 mm Hg, the supravalvular 
gradient was 29 mm Hg and the valvular gradient was 36 mm Hg. 
Balloon dilation eliminated the valvular gradient and reduced the 
supravalvular stenosis to 22 mm Hg. It is hoped the small, residual 
supra valvular gradient will remain so as he grows. 
The fifth case was a 7 -year-old boy who had his Tetralogy of 
Fallot repaired at 2 years of age, requiring a transannular patch for 
a hypoplastic pulmonary annulus. Postoperative Doppler 
echocardiograms demonstrated a progressive increase in the sys-
tolic gradient across the pulmonary outflow tract. At cardiac 
catheterization, the gradient measured 36 mm Hg. Because of the 
large diameter of the pulmonary annulus, balloon angioplasty was 
performed using the double-balloon technique21 • The 2 balloons 
were inflated simultaneously and produced a total balloon diam-
eter of 30 mm; the post-dilation gradient was 26 mm Hg. 
Discussion 
Several years after the first report by Kan, it became obvious 
based on the numerous reports from large medical centers 
throughout the world that pulmonary balloon valvuloplasty was 
effective in relieving valvular stenosis and is the procedure of 
choice over surgical valvotomy; it can be carried out safely in 
regional hospitals. Although not as successful, dilation of periph-
eral pulmonary artery obstructions also have been accomplished. 
Recently 5 cases were treated at Straub Clinic & Hospital, the first 
cases of balloon pulmonary valvulo/angioplasty performed in 
Hawaii. These cases also demonstrate the different clinical situa-
tions in which this technique is applicable; that is, valvular 
stenosis, congenital pulmonary artery stenosis, and postoperative 
pulmonary artery stenosis. 
The indication for balloon valvuloplasty is the same as for 
surgical valvotomy; that is, a systolic gradient in excess of 50 mm 
Hg. There have been recent recommendations to lower this 
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criterion to 35 mm Hg16, primarily because the procedure is 
relatively noninvasive as compared to surgery, and because an 
obstruction severe enough to result in a 35 mm Hg gradient might 
eventually result in irreversible right-ventricular cardiomyopathy. 
Complications have been few and are listed in Table 1. 
Selecting the proper catheter size helps to avoid injury to the vessel 
wall. Arrhythmias and transient hypotension do occur and are 
associated with the balloon inflation, but resolve rapidly after-
ward. Unless there is a significant injury inadvertent to the 
myocardium, there usually are no other significant arrhythmias. 
Cumulative results from some of the larger series reported 
elsewhere5•9.I5•16•17•18 and comparison with results of surgical 
valvulotomy13 are shown in Table 2. The operative mortality is 
comparable, with valvuloplasty appearing to have the edge over 
surgical valvotomy when all ages are considered. 
Initially when the size of the balloons used was limited to the 
diameter of the valve annulus, 60% to 70% of patients had 
significant residual gradients greater than 25 mm Hg6,20. It then 
was demonstrated that balloon sizes up to 40% larger than the 
valve annulus diameter could be used safely and results improved 
with only 7% to 11% of patients having significant residual 
gradients. The pulmonic regurgitation resulting after either surgi-
cal valvotomy or balloon valvuloplasty is usually mild and clinically 
not significant. 
In patients with peripheral pulmonary artery stenosis, ap-
proximately 55% of the vessels are successfully dilated with an 
increase in angiographic diameter by over 50%8• 
Table 3 summarizes the results of Straub's 5 cases. 
Valvular stenosis is relieved by the balloon tearing tissue 
along the path of least resistance by splitting the fused commis-
sures or by tearing through the cusp itself, and sometimes by 
avulsion of the cusp from the annulus20• In our 2 cases with 
valvular stenosis, the gradients across the valve were significantly 
reduced and postvalvuloplasty cineangiocardiograms demon-
strated increased systolic valve opening. 
Dilation of congenital peripheral pulmonary artery stenosis is 
probably accomplished in much the same manner as dilation of 
coarctation of the aorta; that is, by tearing of the intima7• However 
restenosis can occur with accumulation of fibrous tissue in the healing 
process.Inourpatientwithacombinationofvalvularandsupravalvular 
stenosis, the latter obstruction was partially relieved by dilation. 
There are few reports of results following dilation of postop-
erative residual pulmonary artery stenosis. In ourfrrst patient, who 
had repair of a Tetralogy of Fallot and who developed a residual 
stenosis at the area of the transannular patch, tearing fibrous tissue 
within the patch may have been the mechanism responsible for the 
partial reduction of the obstruction. However, the discrepancy in 
size between the dilated proximal and narrow distal main pulmonary 
artery was not remediable to further balloon dilation and the 
patient required further surgery. 
The patient with the aortic homograft obstruction appears to 
have had only a temporary successful result. In his situation, the 
stenotic area may have been stretched but gradually recoiled to its 
previous state. 
Repeat catheterization of some of these patients in the future 
will enable us to evaluate the long-term results of balloon dilation 
and the ability of this technique to permanently relieve obstruction 
of pulmonary valves and arteries. 
HAWAII MEDICAL JouRNAL-VoL. 52, No. 2-FEBRUARY 1993 
Summary 
Five patients with a combined expe-
rience of pulmonary valvular stenosis (2 
cases), congenital supravalvular stenosis 
(1 case), and postoperative residual pul-
monary artery stenosis (3 cases) are pre-
sented along with the results of balloon 
dilation of these lesions. Balloon dilation 
was successful in the 2 valvular lesions, 
partially successful in 1 patient with 
supravalvularstenosis,andhelpfulin 1 out 
of3 patients with postoperative pulmonary 
artery stenosis. Balloon dilation is the 
treatment of choice in valvular pulmonic 
stenosis and may be helpful in congenital 
and acquired pulmonary artery obstructions. 
REFERENCES 
1. Adams FH. Emmanouilides GC, 
Riemenschneider TA. Heart disease in in-
fants, children, and adolescents. 4th ed. Bal-
timore, Md: Williams & Wilkins; 1989. 
2. Ali KahnMA, AI-YousefS, HuhtaJC, Bricker 
IT, Mullins CE, Sawyer W. Critical pulmonary 
valve stenosis in patients less than 1 year of 
age: Treatment with percutaneous gradational 
balloon pulmonary valvuloplasty. Am Heart 
J. 117:1008-1014, 198. 
3. Dotter CT, Judkins MP. Transluminal treat-
ment of arteriosclerotic obstruction. Descrip-
tion of a new technique and a preliminary 
report of its application. Circulation. 30: 654-
670 194. 
4. KanJS, WhiteRIJr,MitchellSE,GardnerTJ. 
Percutaneous balloon valvuloplasty: A new 
method for treating congenital pulmonary 
valve stenosis. N Eng! J Med. 1982:307:540-
542. 
5. Kan JS, White RSI Jr, Mitchell SE, Anderson 
JSH, Gardner TJ. Percutaneous transluminal 
balloon valvuloplasty for pulmonary valve 
stenosis. Circulation. 1984: 69:554-560. 
6. Lababidi Z, Wu J. Percutaneous balloon pul-
monary valvuloplasty. Am J Cardiol. 
1983:52:560-562. 
7. Lock JE, Castaneda-Zuniga WR, Fuhrman 
BP, Bass JL. Balloon dilation angioplasty of 
hypoplastic and stenotic pulmonary arteries. 
Circulation. 1983: 67:96Z-967. 
8. Lock JE, Keane JF, Fellows KE. Diagnostic 
and interventional catheterization in congenital 
heart disease. Boston, Mass: Martinus Nijhoff 
Publishing; 1987. 
9. Marantz PM, Huhta JC, Mullins CE, Murphy 
DJ, Nihill MR, Sludomirsky A, Yoon GY. 
Results of balloon valvuloplasty in typical 
and dysplastic pulmonary valve stenosis: 
Doppler echocardiographic follow-up. J Am 
Coli Cardiol. 1988:12:476-479. 
10. Martin EC, Diamond NG, Casarella WJ. 
Percutaneous transluminal angioplasty in 
nonatherosclerotic disease. Radiology. 
1980:135:27-33. 
11. Mudd CM, Walter KF, Wilman VL. Pulmo-
nary artery stenosis: diagnostic and therapeu-
ticconsideration.Amf MedSci. 1965:249:125. 
12. Mullins CE, Nihill MR, Vick GW III, 
Ludomirski A, O'Laughlin MP, Bricker JT, MK. Long-term results of balloon pulmonary 
Judd VE. Double-balloon technique for dila- valvuloplasty of valvar pulmonic stenosis. 
tion of valvular or vessel stenosis in congenital Am Heart J. 1988:115:1291-1296. 
and acquired heart disease. JA CC. 1987: 10: 18. Rey C, Marache P, Francart C, Dupuis C. 
107-114. Percutaneous transluminal balloon 
13. Nugent EW, Freedom RM, Nora JJ, Ellison valvuloplasty of congenital pulmonary valve 
RC, Rowe RD, Nadas AS. Clinical course in stenosis. with a special report on infants and 
pulmonary stenosis. Circulation. 1977: Supp neonates.JAmCollCardio/.1988:11:815-820. 
I, 56:1-38-I-47. 19. Rocchini AP, K veselis DA, Crowley D, Dick 
14. Pepine CJ, Gessner IH, Feldman RL. Percu- M, Rosenthal A. Percutaneous balloon 
taneous balloon valvuloplasty for pulmonic valvuloplasty for treatment of congenital 
valve stenosis in the adult. Am J Cardiol. pulmonary valvar stenosis in children. JAm 
1982:50: 1442-1445. Coli Cardiol. 1984:3:1005-1012. 
15. Radtke W, Keane JF, Fellows KE, Lang P, 20. Walls JT, Lababidi Z, Curtis JJ, Silver D. 
Lock JE. Percutaneous balloon valvotomy of Assessment of percutaneous balloon pulmo-
congenital pulmonary stenosis using over- nary and aortic valvuloplasty. J Thorac 
sized balloons.] Am Coli Cardiol. 1986:8:909- Cardiovasc Surg. 1984:88:352-356. 
915. 21. Zeevi B, Keane JF, Fellows KE, Lock JE. 
16. Radtke W, Lock J. Balloon dilation. Ped Cl Balloon dilation of critical pulmonary stenosis 
NA. 1990:37:193. in the first week of life. JAm Coli Cardiol. 
17. Rao PS, Fawzy ME, Solymar L, Mardini 1988:11:821-824. 
• 
TABLE 1. Potential complications of balloon dilation 
1. Rupture of the pulmonary artery. 
2. Contusion to the right ventricular outflow tract. 
3. Transient hypotension. 
4. Ventricular ectopic beats during balloon inflation. 
TABLE2. Comparative results of surgical valvotomy and 
balloon valvuloplasty for valvular pulmonic stenosis 
Surgery Valvuloplasty 
Mortality < 10% <2yrs < 0.5% all ages 
<0.5% > 2 yrs 
Residual gradient 81% 89-93% 
<25mm Hg. 
Residual pulmonic 50% 20% 
regurgitation 
TABLE3. Results of balloon dilation 
Before After 
RV PA RV PA RV Press PAGrad 
Press GRAD Press Grad Reduction Reduction 
MMHG MMHG MMHG MMHG % % 
Case#1 (A) 139 110 86 58 38 47 
105 58 94 54 10 7 
Case #2 (V) 110 96 50 38 55 60 
71 58 32 14 55 76 
Case #3 (H) 89 47 42 24 53 49 
(H) 82 56 
Case #4 (V,S) 72 36v 46 Ov 36 100v 
29s 22s 24s 
Case#5 (A) 58 36 46 26 21 28 
A= artery H= homograft 
V=valve S= supravalvular 
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